طاسی به وضعیت نداشتن مو و یا از دست دادن آن در نواحی ای که مو در آن نواحی اغلب رشد میکند، و به خصوص در سر، اطلاق میشود. شایعترین و معمولترین شکل طاسی، نوعی روند پیشروندهٔ از دست دادن مو میباشد که بدان آلوپسی آندروژنیک یا طاسی ، با الگوی مردانه گفته میشود و در انسان بالغ با جنسیت نر و همینطور در گونههای دیگر جز انسان رخ میدهد.
میزان طاسی و الگوهای ریزش مو در این حالت، میتوانند تا حد زیادی متفاوت باشند، و انواع گوناگونی را از طاسی با الگوی مردانه و زنانه (که آلوپسی آندروژنیک، آلوپسی آندروژنتیک، و آلوپسی آندروژنتیکا نیز نامیده میشود و در فارسی میتوان آن را به طاسی وابسته به هورمون مردانه و یا کچلی آندروژنیک نیز ترجمه کرد) گرفته، تا مواردی همچون طاسی منطقهای یا همان آلوپسی آره آتا، که شامل از دست دادن منطقهای مو در برخی از نواحی سر یا بدن است، و همینطور طاسی کامل یا همان آلوپسی توتالیس، که به از دست دادن تمامی موی سر به طور کامل اطلاق میگردد، و نیز ریزش مو یا طاسی سرتاسری یا همان آلوپسی یونیورسالیس، که شامل از دست دادن تمام موهای سر و بدن میباشد را، در بر میگیرد.
آلوپسی آندروژنیک مردانه یا طاسی مردانه ریزش مو تیپ مردانه را نمیتوان یک بیماری محسوب نمود. این وضعیت به طور معمول در مردانی که از نظر ژنتیکی مستعد این وضعیت هستند اتفاق میافتد و در واقع نوعی پاسخ فیزیولوژیک بدن آنها به آندروژنها یا همان هورمونهای مردانه میباشد.
موهای ناحیه سر در انسان با وجودیکه رشد غیر وابسته به هورمون جنسی مردانه (آندروژن) دارند، امّا دارای گیرندهٔ خاص هورمونهای جنسی میباشند و به همین دلیل این هورمونها میتوانند بر ریزش مو موثر باشند. در مردان بخشهای فرونتوتمپورال یعنی نواحی جلو و اطراف و مرکز سر دارای گیرنده هورمونی هستند امّا در زنان تمام موهای ناحیه سر دارای گیرنده آندروژنی میباشند. به همین دلیل در مردان اول ناحیه جلوی سر کاهش مو داریم و بعد ناحیه مرکزی و سپس این دو ناحیه بهم میرسند.
برای درمان الوپسی مردانه از مینوکسیدیل موضعی و روشهای جراحی مختلف میتوان سود برد. بهترین کاندیداهای درمان با مینوکسیدیل مردان با سن کمتر از ۳۰ سال هستند که کمتر از ۵ سال است دچار ریزش مو شدهاند.
آلوپسی آندروژنیک زنانه یا طاسی زنانه را گاهی آلوپسی آندروژنیک آدرنال زنانه هم میخوانند، چرا که در برخی از این زنان سطح سرمی دهیدرواپی آندروسترون سولفات (DHEAS) که نوعی آندروژن غده فوق کلیه (آدرنال) است، بالا میباشد. در این زنان طرح مشخصی از آلوپسی مرکزی اسکالپ بدون فرورفتگی فرونتوتمپورال پدید میآید ولی دز زنان کاهش مو در تمام سر بطور یکسان پدید میآید و زنان مانند مردان دچار طاسی سر نمیشوند.
آلوپسی آره آتا یا طاسی منطقهای بیماری است که با آغاز سریع ریزش مو در یک منطقه کاملاً مشخص و معمولاً مدور تشخیص داده میشود. اکثریت بیماران زیر 60 سال سن دارند و هیچ یافته دیگری به همراه ندارند. علت این بیماری میتواند اختلالات سیستم ایمنی مانند کم خونی ایمنی، التهاب تیروئید، دیابت و... باشد.
مبتلایان به طاسی منطقهای در یک سوم موارد خودبخود بهبود مییابند و نیازی به درمان ندارند ولی در موارد شدید میتوان از داروهای کورتون (موضعی یا تزریق داخل جلدی)، ماینوکسیدیل، پووا تراپی و... استفاده کرد.
کورتون موضعی مانند تریامسینولون را نباید به مقدار زیاد استفاده کرد چون کاهش بافت پوست و آتروفی آنرا بدنبال دارد. اگر مناطق درگیر در این بیماری زیاد باشند، یا درگیری منتشر باشد، یا مژهها و ابروها درگیر باشند، و همچنین اگر با حساسیت همراه باشد و... وخامت این بیماری بیشتر خواهد داشت.
طاسی کامل یا آلوپسی توتالیس به ریزش تمام موی سر اطلاق میشود. این بیماری دارای دورههای رشد و ریزش مو میباشد، هرچند که پروگنوز یا پیش آگهی رشد طولانی مدت مو در آن ضعیف است.
طاسی سرتاسری یا آلوپسی یونیورسالیس به ریزش تمام موی بدن اطلاق میشود، که بسیار نادر است.
راههای درمان طاسی[ویرایش]
کاشت مو به تکنیک جراحی گفته میشود که در آن ریشههای مو، تک تک از ناحیه اهدا کننده به ناحیه در حال ریزش و یا خالی از مو برده میشوند.
"Bald" redirects here. For other uses, see Bald (disambiguation).
"Alopecia" redirects here. For an album by Why?, see Alopecia (album).
Hair loss and hypotrichosis have many causes including androgenetic alopecia, fungal infection, trauma (e.g., due to (trichotillomania), radiotherapy, chemotherapy, nutritional deficiencies (e.g., iron deficiency), and autoimmune diseases (e.g., alopecia areata). Hair loss severity occurs across a spectrum with extreme examples including alopecia totalis (total loss of hair on the head) and alopecia universalis (total loss of all hair on the head and body).
Baldness is the partial or complete lack of hair growth, and part of the wider topic of "hair thinning". The degree and pattern of baldness varies, but its most common cause is androgenic alopecia, alopecia androgenetica, or alopecia seborrheica, with the last term primarily used in Europe.
Signs and symptoms
Symptoms of hair loss include hair loss in patches usually in circular patterns, dandruff, skin lesions, and scarring. Alopecia areata (mild - medium level) usually shows in unusual hair loss areas e.g. eyebrows, backside of the head or above the ears where usually the male pattern baldness does not affect. In male-pattern hair loss, loss and thinning begin at the temples and the crown and either thins out or falls out. Female-pattern hair loss occurs at the frontal and parietal.
People have between 100,000 and 150,000 hairs on their head. The number of strands normally lost in a day varies, but on average is 100. In order to maintain a normal volume, hair must be replaced at the same rate at which it is lost. The first signs of hair thinning that people will often notice are more hairs than usual left in the hairbrush after brushing or in the basin after shampooing. Styling can also reveal areas of thinning, such as a wider parting or a thinning crown.
A substantially blemished face, back and limbs could point to cystic acne. The most severe form of the condition, cystic acne arises from the same hormonal imbalances that cause hair loss, and is associated with dihydrotestosterone production. Seborrheic dermatitis, a condition in which an excessive amount of sebum is produced and builds up on the scalp (looking like an adult cradle cap) is also a symptom of hormonal imbalances, as is an excessively oily or dry scalp. Both can cause hair thinning.
Hair thinning and baldness cause psychological stress due to their effect on appearance. Although societal interest in appearance has a long history, this particular branch of psychology came into its own during the 1960s and has gained momentum as messages associating physical attractiveness with success and happiness grow more prevalent.
The psychology of hair thinning is a complex issue. Hair is considered an essential part of overall identity: especially for women, for whom it often represents femininity and attractiveness. Men typically associate a full head of hair with youth and vigor. Although they may be aware of pattern baldness in their family, many are uncomfortable talking about the issue. Hair thinning is therefore a sensitive issue for both sexes. For sufferers, it can represent a loss of control and feelings of isolation. People experiencing hair thinning often find themselves in a situation where their physical appearance is at odds with their own self-image and commonly worry that they appear older than they are or less attractive to others. Psychological problems due to baldness, if present, are typically most severe at the onset of symptoms.
Hair loss induced by cancer chemotherapy has been reported to cause changes in self-concept and body image. Body image does not return to the previous state after regrowth of hair for a majority of patients. In such cases, patients have difficulties expressing their feelings (alexithymia) and may be more prone to avoiding family conflicts. Family therapy can help families to cope with these psychological problems if they arise.
Although not completely understood, hair loss can have many causes:
Male pattern baldness
Main article: Androgenic alopecia
More than 95% of hair loss in men is male pattern baldness (MPB). MPB is characterized by hair receding from the lateral sides of the forehead (known as a "receding hairline") and/or a thinning crown (balding to the area known as the ‘vertex’). Both become more pronounced until they eventually meet, leaving a horseshoe-shaped ring of hair around the back of the head.
The incidence of pattern baldness varies from population to population and is based on genetic background. Environmental factors do not seem to affect this type of baldness greatly. One large scale study in Maryborough, Victoria, Australia showed the prevalence of mid-frontal baldness increases with age and affects 73.5 percent of men and 57 percent of women aged 80 and over. A rough rule of thumb is that the incidence of baldness in males corresponds roughly to chronological age. For example, according to Medem Medical Library's website, MPB affects roughly 40 million men in the United States. Approximately one in four men will have noticeable hair loss by age 30, and this figure increases to two in three men by age 60. In rare cases, MPB can begin as early as age 12.
The genetics of MPB are not yet fully understood. Most likely there are multiple genes that contribute towards MPB, the most important of which appears to be the Androgen Receptor gene, located on the X chromosome (inherited from the mother). It was previously believed that baldness was inherited from the maternal grandfather. While there is some basis for this belief, it is now known that both parents contribute to their offspring's likelihood of hair loss. Most likely, inheritance involves many genes with variable penetrance.[medical citation needed]
The trigger for this type of baldness is dihydrotestosterone, a more potent form of testosterone often referred to by its acronym DHT. DHT is an androgenic hormone, body- and facial-hair growth promoter that can adversely affect the prostate as well as the hair located on the head. The mechanism by which DHT accomplishes this is not yet fully understood. In genetically prone scalps (i.e., those experiencing male or female pattern baldness), DHT initiates a process of follicular miniaturization, in which the hair follicle begins to deteriorate. As a consequence, the hair’s growth phase (anagen) is shortened, and young, unpigmented vellus hair is prevented from growing and maturing into the deeply rooted and pigmented terminal hair that makes up 90 percent of the hair on the head. In time, hair becomes thinner, and its overall volume is reduced so that it resembles fragile vellus hair or "peach fuzz" until, finally, the follicle goes dormant and ceases producing hair completely.
Hair loss often follows childbirth without causing baldness. In this situation, the hair is actually thicker during pregnancy due to increased circulating oestrogens. After the baby is born, the oestrogen levels fall back to normal prepregnancy levels, and the additional hair foliage drops out. A similar situation occurs in women taking the fertility-stimulating drug clomiphene.
Causes of alopecia include:
Hair follicle growth occurs in cycles. Each cycle consists of a long growing phase (anagen), a short transitional phase (catagen) and a short resting phase (telogen). At the end of the resting phase, the hair falls out (exogen) and a new hair starts growing in the follicle beginning the cycle again.
Normally, about 40 (0–78 in men) hairs reach the end of their resting phase each day and fall out. When more than 100 hairs fall out per day, clinical hair loss (telogen effluvium) may occur. A disruption of the growing phase causes abnormal loss of anagen hairs (anagen effluvium).
Because they are not usually associated with an increased loss rate, male-pattern and female-pattern hair loss do not generally require testing. If hair loss occurs in a young man with no family history, drug use could be the cause.
There are two types of identification tests for female pattern baldness: the Ludwig Scale and the Savin Scale. Both track the progress of diffused thinning, which typically begins on the crown of the head behind the hairline, and becomes gradually more pronounced. For male pattern baldness, the Hamilton–Norwood scale tracks the progress of a receding hairline and/or a thinning crown, through to a horseshoe-shaped ring of hair around the head and on to total baldness.
In almost all cases of thinning, and especially in cases of severe hair loss, it is recommended to seek advice from a doctor or dermatologist. Many types of thinning have an underlying genetic or health-related cause, which a qualified professional will be able to diagnose.
See also: Management of hair loss
Treatments for the various forms of hair loss have limited success. Three medications have evidence to support their use in male pattern hair loss: finasteride, dutasteride and minoxidil. They typically work better to prevent further hair loss than to regrow lost hair.
Hair transplantation is usually carried out under local anaesthetic. A surgeon will move healthy hair from the back and sides of the head to areas of thinning. The procedure can take between four and eight hours, and additional sessions can be carried out to make hair even thicker. Transplanted hair falls out within a few weeks, but regrows permanently within months. Hair transplants, takes tiny plugs of skin, each which contains a few hairs, and implants the plugs into bald sections. The plugs are generally taken from the back or sides of the scalp. Several transplant sessions may be necessary.
Hiding hair loss
One method of hiding hair loss is the "comb over", which involves restyling the remaining hair to cover the balding area. It is usually a temporary solution, useful only while the area of hair loss is small. As the hair loss increases, a comb over becomes less effective.
Another method is to wear a hat or a hairpiece—a wig or toupee. The wig is a layer of artificial or natural hair made to resemble a typical hair style. In most cases the hair is artificial. Wigs vary widely in quality and cost. In the United States, the best wigs—those that look like real hair—cost up to tens of thousands of dollars. Organizations also collect individuals' donations of their own natural hair to be made into wigs for young cancer patients who have lost their hair due to chemotherapy or other cancer treatment in addition to any type of hair loss.
Though not as common as the loss of hair on the head, chemotherapy, hormone imbalance, forms of hair loss, and other factors can also cause loss of hair in the eyebrows. Loss of growth in the outer one third of the eyebrow is often associated with hypothyroidism. Artificial eyebrows are available to replace missing eyebrows or to cover patchy eyebrows. Eyebrow embroidery is another option which involves the use of a blade to add pigment to the eyebrows. This gives a natural 3D look for those who are worried about an artificial look and it lasts for two years. Micropigmentation (permanent makeup tattooing) is also available for those who want the look to be permanent.
Hypothermia caps may be useful to prevent hair loss during some kinds of chemotherapy, specifically when tazanes or anthracyclines are used. It should not be used when cancer is present in the skin of the scalp or for lymphoma or leukemia. There are generally only minor side effects from treatment.
Instead of concealing hair loss, some may embrace it by shaving their head. A shaved head will grow stubble in the same manner and at the same rate as a shaved face. The general public has become accepting of the shaved head as well, though female baldness can be considered less socially acceptable in various parts of the world.
Dietary supplements are not typically recommended. There is only one small trial of saw palmetto which shows tentative benefit in those with mild to moderate androgenetic alopecia. There is no evidence for biotin. Evidence for most other produces is also insufficient. There was no good evidence for gingko, aloe vera, ginseng, bergamot, hibiscus, or sorphora as of 2011.
Many people use unproven treatments. Egg oil, in Indian, Japanese, Unani (Roghan Baiza Murgh) and Chinese traditional medicine, was traditionally used as a treatment for hair loss.[medical citation needed]
Research is looking into connections between hair loss and other health issues. While there has been speculation about a connection between early-onset male pattern hair loss and heart disease, a review of articles from 1954 to 1999 found no conclusive connection between baldness and coronary artery disease. The dermatologists who conducted the review suggested further study was needed.
Environmental factors are under review. A 2007 study indicated that smoking may be a factor associated with age-related hair loss among Asian men. The study controlled for age and family history, and found statistically significant positive associations between moderate or severe male pattern hairloss and smoking status.
Vertex baldness is associated with an increased risk of coronary heart disease (CHD) and the relationship depends upon the severity of baldness, while frontal baldness is not. Thus, vertex baldness might be a marker of CHD and is more closely associated with atherosclerosis than frontal baldness.
Hair follicle aging
A key aspect of hair loss with age is the aging of the hair follicle. Ordinarily, hair follicle renewal is maintained by the stem cells associated with each follicle. Aging of the hair follicle appears to be primed by a sustained cellular response to the DNA damage that accumulates in renewing stem cells during aging. This damage response involves the proteolysis of type XVII collagen by neutrophil elastase in response to the DNA damage in the hair follicle stem cells. Proteolysis of collagen leads to elimination of the damaged cells and then to terminal hair follicle miniaturization.
The term alopecia (//) is from the Classical Greek ἀλώπηξ, alōpēx, meaning "fox". The origin of this usage is because this animal sheds its coat twice a year, or because in ancient Greece foxes often lost hair because of mange.